V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017666 | 220008539 | 1.83 | 88.6 | Curative (C) | 2013-05-27 | 2013-07-02 | ATG + Busulfan + Fludarabine | 2 | N | 220032265 | ATG + BUSULFAN + FLUDARABINE |
| 220017667 | 220014619 | 1.79 | null | Curative (C) | 2016-03-20 | 2016-03-20 | IDARUBICIN + TRETINOIN | N | N | 220032271 | IDARUBICIN + TRETINOIN |
| 220017668 | 220008542 | 1.74 | 68 | null | 2014-01-01 | 2014-01-01 | Triple / Double Intrathecal Therapy | 02 | N | 220032272 | TRIPLE INTRATHECAL |
| 220017669 | 220008546 | 1.7 | 0 | null | 2017-09-06 | 2017-09-11 | IDARUBICIN + TRETINOIN | 2 | N | 220032286 | IDARUBICIN + TRETINOIN |
| 220017670 | 220008550 | 1.62 | 73.5 | Curative (C) | 2015-01-07 | 2015-01-15 | Triple / Double Intrathecal Therapy | N | null | 220032293 | TRIPLE INTRATHECAL |
| 220017671 | 220008553 | null | 92 | Palliative (P) | 2018-02-24 | 2018-02-24 | AML Int Guide ADE 8+3+5 (2) | 2 | N | 220032313 | ADE |
| 220017672 | 220008556 | 1.84 | 65.9 | Disease modification (D) | 2018-08-15 | 2018-08-20 | AML Int Guide ADE 10+3+5 (1) | 2 | N | 220032316 | ADE |
| 220017673 | 220008558 | null | 109 | Palliative (P) | 2016-11-16 | 2016-11-30 | IDARUBICIN + TRETINOIN | 02 | N | 220032319 | IDARUBICIN + TRETINOIN |
| 220017674 | 220008558 | 1.7 | null | null | 2017-05-22 | 2017-05-23 | ATG + Busulfan + Fludarabine | 02 | null | 220032319 | ATG + BUSULFAN + FLUDARABINE |
| 220017675 | 220008560 | 1.65 | null | null | 2014-11-27 | 2014-12-01 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 220032328 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017676 | 220008563 | 1.66 | 51.9 | Disease modification (D) | 2015-08-25 | 2015-10-03 | AML16 DA 2+5 | 02 | N | 220032331 | AML16 TRIAL |
| 220017677 | 220008566 | 1.83 | 68.4 | Not known (9) | 2015-01-04 | 2015-01-11 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220032344 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017678 | 220008567 | 1.73 | 57 | Curative (C) | 2016-10-01 | 2017-05-02 | CYCLOPHOSPHAMIDE | 2 | N | 220032348 | CYCLOPHOSPHAMIDE |
| 220017679 | 220014628 | 0.96 | 58.7 | Palliative (P) | 2014-05-08 | 2014-05-09 | Triple / Double Intrathecal Therapy | 2 | N | 220032351 | TRIPLE INTRATHECAL |
| 220017680 | 220008572 | 1.51 | 41.5 | Palliative (P) | 2012-07-03 | 2014-09-03 | IDARUBICIN + TRETINOIN | N | N | 220032358 | IDARUBICIN + TRETINOIN |
| 220017682 | 220008574 | 1.55 | 57.1 | Palliative (P) | 2013-08-30 | 2013-08-30 | BOSUTINIB | null | null | 220032371 | BOSUTINIB |
| 220017683 | 220014633 | 1.62 | 68.8 | Palliative (P) | 2014-08-06 | 2014-08-06 | Cyclophosphamide+Fludara+TBI Allo | 02 | N | 220032372 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017684 | 220008578 | null | null | null | null | 2013-10-19 | Methotrexate intrathecal | N | N | 220032378 | METHOTREXATE INTRATHECAL |
| 220017685 | 220008582 | 1.7 | 89.4 | Adjuvant (A) | 2017-01-20 | 2017-03-03 | RUXOLITINIB | N | null | 220032382 | RUXOLITINIB |
| 220017686 | 220014634 | null | 74 | Curative (C) | 2013-06-26 | 2013-06-26 | ATG + Busulfan + Fludarabine | N | N | 220032382 | ATG + BUSULFAN + FLUDARABINE |
| 220017687 | 220014635 | 0 | 78 | Curative (C) | 2013-09-26 | 2013-09-26 | AML16 DA 3+10 | N | N | 220032392 | AML16 TRIAL |
| 220017688 | 220014636 | 1.75 | 80.1 | Adjuvant (A) | 2016-04-07 | 2016-05-09 | Triple / Double Intrathecal Therapy | N | N | 220032405 | TRIPLE INTRATHECAL |
| 220017689 | 220008589 | 1.69 | 77.1 | Not known (9) | 2014-01-30 | 2014-03-02 | Triple Intrathecal | Y | N | 220032418 | TRIPLE INTRATHECAL |
| 220017690 | 220008592 | 1.63 | 63.1 | Palliative (P) | 2017-03-24 | 2017-03-25 | BOSUTINIB | N | N | 220032421 | BOSUTINIB |
| 220017691 | 220014641 | 1.65 | 42.8 | Palliative (P) | 2017-03-29 | 2017-03-29 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220032429 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017692 | 220014641 | 1.66 | 46.7 | Curative (C) | 2013-11-10 | 2013-11-25 | ATG + Busulfan + Fludarabine | N | N | 220032429 | ATG + BUSULFAN + FLUDARABINE |
| 220017693 | 220014642 | 0 | 18.3 | Disease modification (D) | null | 2016-01-02 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220032447 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017694 | 220008596 | null | 18.3 | Curative (C) | null | 2013-05-26 | Triple / Double Intrathecal Therapy | N | N | 220032460 | TRIPLE INTRATHECAL |
| 220017695 | 220008598 | null | 53.1 | Curative (C) | null | 2016-08-20 | IDARUBICIN + TRETINOIN | 02 | N | 220032464 | IDARUBICIN + TRETINOIN |
| 220017696 | 220008603 | null | 98.1 | Curative (C) | 2017-06-25 | 2017-06-25 | BOSUTINIB | N | N | 220032476 | BOSUTINIB |
| 220017697 | 220008604 | 1.58 | 0 | Not known (9) | 2013-07-20 | 2013-07-26 | Triple / Double Intrathecal Therapy | null | N | 220032476 | TRIPLE INTRATHECAL |
| 220017698 | 220008609 | 0 | null | Palliative (P) | 2015-04-20 | 2015-04-22 | Cyclophosphamide TBI Allograft | N | N | 220032501 | CYCLOPHOSPHAMIDE |
| 220017699 | 220008611 | 1.61 | 71.8 | Palliative (P) | 2014-01-28 | 2014-04-01 | FLAG | N | N | 220032519 | FLAG |
| 220017700 | 220008615 | 1.75 | 78.7 | Curative (C) | 2015-08-15 | 2015-08-15 | AML Int Guide ADE 8+3+5 (2) | 02 | N | 220032524 | ADE |
| 220017701 | 220008618 | null | 68 | null | 2015-09-21 | 2015-09-28 | CYCLOPHOSPHAMIDE + FLUDARABINE | null | N | 220032527 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017702 | 220008620 | 1.69 | 57.1 | null | 2015-11-20 | 2015-11-23 | Cyclophosphamide+Fludara+TBI Allo | 02 | N | 220032532 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017703 | 220008627 | 1.67 | 25.8 | Disease modification (D) | 2014-11-20 | 2015-02-23 | IDARUBICIN + TRETINOIN | null | null | 220032555 | IDARUBICIN + TRETINOIN |
| 220017704 | 220008629 | 1.68 | 39.7 | Curative (C) | 2017-06-11 | 2017-06-14 | AML16 DA 3+10 | 2 | N | 220032572 | AML16 TRIAL |
| 220017705 | 220008633 | 1.6 | 55 | Curative (C) | 2014-02-03 | 2014-02-04 | Methotrexate intrathecal | N | N | 220032602 | METHOTREXATE INTRATHECAL |
| 220017706 | 220014659 | 1.57 | 87 | Palliative (P) | 2016-01-01 | 2016-02-04 | IDARUBICIN + TRETINOIN | N | null | 220032603 | IDARUBICIN + TRETINOIN |
| 220017707 | 220008638 | 1.69 | 67.8 | null | 2016-06-05 | 2016-06-16 | RUXOLITINIB | Y | N | 220032608 | RUXOLITINIB |
| 220017708 | 220008640 | null | 56 | Curative (C) | 2015-12-28 | 2015-12-28 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220032610 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017709 | 220008643 | 1.58 | 69.4 | Curative (C) | null | 2017-08-16 | FLAG | N | null | 220032615 | FLAG |
| 220017710 | 220008646 | null | 0 | Disease modification (D) | 2015-07-21 | 2015-07-24 | BOSUTINIB | N | null | 220032618 | BOSUTINIB |
| 220017711 | 220014663 | 0 | 88.9 | Palliative (P) | 2013-10-02 | 2013-10-03 | Cyclophosphamide TBI Allograft | N | N | 220032628 | CYCLOPHOSPHAMIDE |
| 220017712 | 220008649 | 1.7 | 99.2 | Curative (C) | 2013-10-11 | 2014-03-12 | Triple / Double Intrathecal Therapy | 2 | N | 220032635 | TRIPLE INTRATHECAL |
| 220017714 | 220008653 | null | 8.8 | Disease modification (D) | null | 2016-10-15 | FLAG | null | N | 220032654 | FLAG |
| 220017715 | 220008654 | null | null | Curative (C) | 2015-08-12 | 2015-10-01 | BOSUTINIB | N | N | 220032654 | BOSUTINIB |
| 220017716 | 220008657 | 1.96 | 75 | Curative (C) | 2015-01-08 | 2015-01-08 | Triple / Double Intrathecal Therapy | N | N | 220032656 | TRIPLE INTRATHECAL |
| 220017717 | 220008659 | 1.68 | 54.7 | null | 2018-07-05 | 2018-07-24 | BOSUTINIB | 2 | N | 220032658 | BOSUTINIB |